177 related articles for article (PubMed ID: 29284696)
1. Re-Evaluating the Possible Increased Risk of HIV Acquisition With Progestin-Only Injectables Versus Maternal Mortality and Life Expectancy in Africa: A Decision Analysis.
Rodriguez MI; Gaffield ME; Han L; Caughey AB
Glob Health Sci Pract; 2017 Dec; 5(4):581-591. PubMed ID: 29284696
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis.
Rodriguez MI; Reeves MF; Caughey AB
BJOG; 2012 Aug; 119(9):1067-73. PubMed ID: 22676150
[TBL] [Abstract][Full Text] [Related]
3. Planning for Outcomes (P
Lebetkin E; Gao X; Taylor D; Maldonado LY; Saad A; Steiner MJ; Dorflinger LJ; Nanda K; Mastro TD
Glob Health Sci Pract; 2019 Jun; 7(2):317-328. PubMed ID: 31189699
[TBL] [Abstract][Full Text] [Related]
4. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
[TBL] [Abstract][Full Text] [Related]
5. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
[TBL] [Abstract][Full Text] [Related]
6. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
Smith JA; Beacroft L; Abdullah F; Buthelezi B; Makua M; Morroni C; Ramjee G; Velasquez C; Hallett TB
J Int AIDS Soc; 2020 Oct; 23(10):e25620. PubMed ID: 33030312
[TBL] [Abstract][Full Text] [Related]
7. Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Callahan R; Yacobson I; Halpern V; Nanda K
Contraception; 2015 Dec; 92(6):514-22. PubMed ID: 26363431
[TBL] [Abstract][Full Text] [Related]
8. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
9. Progestin-only contraception: injectables and implants.
Jacobstein R; Polis CB
Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):795-806. PubMed ID: 24996766
[TBL] [Abstract][Full Text] [Related]
10. Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.
Patel RC; Morroni C; Scarsi KK; Sripipatana T; Kiarie J; Cohen CR
J Int AIDS Soc; 2017 May; 20(1):21396. PubMed ID: 28530033
[TBL] [Abstract][Full Text] [Related]
11. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
Jain AK
Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
[TBL] [Abstract][Full Text] [Related]
12. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM
Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646
[TBL] [Abstract][Full Text] [Related]
13. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
14. RAMOS study confirms contraception saves lives.
Netw Res Triangle Park N C; 1985; 6(4):4-5. PubMed ID: 12340325
[TBL] [Abstract][Full Text] [Related]
15. Complex decisions: correlates of injectable contraceptive discontinuation following HIV-1 seroconversion in an HIV prevention trial.
Caplan MR; Landovitz RJ; Palanee-Phillips T; Nair G; Mhlanga F; Balkus JE; Riddler SA; Gorbach PM
AIDS Care; 2019 Jun; 31(6):746-753. PubMed ID: 30759997
[TBL] [Abstract][Full Text] [Related]
16. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa.
McCoy SI; Zheng W; Montgomery ET; Blanchard K; van der Straten A; de Bruyn G; Padian NS
AIDS; 2013 Mar; 27(6):1001-1009. PubMed ID: 23698064
[TBL] [Abstract][Full Text] [Related]
17. Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk.
Butler AR; Smith JA; Polis CB; Gregson S; Stanton D; Hallett TB
AIDS; 2013 Jan; 27(1):105-113. PubMed ID: 23014519
[TBL] [Abstract][Full Text] [Related]
18. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
[TBL] [Abstract][Full Text] [Related]
19. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
20. Long-term benefits and risks of alternative methods of fertility control in the United States.
Kawachi I; Colditz GA; Hankinson S
Contraception; 1994 Jul; 50(1):1-16. PubMed ID: 7924318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
